Oppenheimer Reiterates Outperform on RXO, Maintains $31 Price Target
Portfolio Pulse from Benzinga Newsdesk
Oppenheimer analyst Scott Schneeberger has reiterated an Outperform rating on RXO, maintaining a price target of $31.
September 17, 2024 | 3:14 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Oppenheimer analyst Scott Schneeberger has reiterated an Outperform rating on RXO, maintaining a price target of $31. This suggests confidence in RXO's potential for growth.
The reiteration of an Outperform rating and maintenance of a $31 price target by a reputable analyst suggests positive sentiment and potential for RXO's stock price to rise. This is likely to influence investor perception positively in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100